Monares ZE, Rodríguez GJH, Valles GA, Galindo MCA, Corrales BEJ, Suárez CA

Idioma: Español
Referencias bibliográficas: 23
Paginas: 319-323
Archivo PDF: 205.81 Kb.

RESUMEN

Introducción: La escala SOFA es una herramienta ampliamente utilizada en las unidades de terapia intensiva. Sin embargo, desde su validación inicial hace casi 20 años, no han sido modificados sus parámetros, cuando los avances médicos y la nueva evidencia nos obligan a realizar ajustes.
Objetivo: Validación de la escala SOFA con modificación del componente cardiovascular en una unidad de terapia intensiva mixta.
Material y métodos: Se realizó un estudio observacional y retrospectivo del registro de pacientes ingresados a la unidad de cuidados intensivos del 1 de agosto de 2014 al 30 de junio de 2015.
Resultados: Un total de 57 casos con promedio de edad de 65 años (± 18) y una mortalidad general de 24.5%. Mediante el análisis de curvas ROC, se obtuvieron los siguientes puntos de corte: APACHE II = 20; SOFA = 6; mCV-SOFA = 6; mCV-SOFA sin lactato = 6; con áreas bajo la curva de: 0.76 (p = 0.003); 0.78 (p = 0.001); 0.89 (p ‹ 0.001); 0.89 (p ‹ 0.001), respectivamente. El lactato inicial, el lactato a las 24 horas y la depuración de lactato no mostraron diferencias significativas (p › 0.05).
Conclusión: En nuestra población, el empleo del SOFA con modificación del componente cardiovascular fue más sensible para predecir mortalidad respecto a la escala original, por lo que su empleo puede tener un mejor desempeño en la detección del riesgo de muerte en pacientes críticos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Vincent JL, Moreno R. Clinical review: scoring systems in the critically ill. Crit Care. 2010;14(2):207. doi: 10.1186/cc8204.

2. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710.

3. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793-800.

4. Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med. 1999;25(7):686-696.

5. Fröhlich M, Wafaisade A, Mansuri A. et - al. Which score should be used for posttraumatic multiple organ failure? - Comparison of the MODS, Denver- and SOFA- Scores. Scand J Trauma Resusc Emerg Med. 2016;24(1):130-138.

6. Lorente JA, Vallejo A, Galeiras R, Tómicic V, Zamora J, Cerdá E, et al. Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients. Shock. 2009;31(2):125-131.

7. Vosylius S, Sipylaite J, Ivaskevicius J. Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis. Croat Med J. 2004;45(6):715-720.

8. Ceriani R, Mazzoni M, Bortone F, Gandini S, Solinas C, Susini G, et al. Chest. Application of the sequential organ failure assessment score to cardiac surgical patients. 2003;123(4):1229-1239.

9. Hernández G, Bruhn A, Castro R, Pedreros C, Rovegno M, Kattan E, et al. Persistent sepsis-induced hypotension without hyperlactatemia: a distinct clinical and physiological profile within the spectrum of septic shock. Crit Care Res Pract. 2012; 2012: 536852.

10. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367-374.

11. Hernández G, Castro R, Romero C, de la Hoz C, Angulo D, Aranguiz I, et al. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock? J Crit Care. 2011;26(4):435.e9-14.

12. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789.

13. Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, et al. Shock. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. 2010;33(4):375-380.

14. Yadav H, Harrison AM, Hanson AC, Gajic O, Kor DJ, Cartin-Ceba R. Improving the accuracy of cardiovascular component of the sequential organ failure assessment score. Crit Care Med. 2015;43(7):1449-1457.

15. Cannon CM, Braxton CC, Kling-Smith M, Mahnken JD, Carlton E, Moncure M. Utility of the shock index in predicting mortality in traumatically injured patients. J Trauma. 2009;67(6):1426-1430.

16. Zarzaur BL, Croce MA, Fischer PE, Magnotti LJ, Fabian TC. New vitals after injury: shock index for the young and age x shock index for the old. J Surg Res. 2008;147(2):229-236.

17. Zarzaur BL, Croce MA, Magnotti LJ, Fabian TC. Identifying life-threatening shock in the older injured patient: an analysis of the National Trauma Data Bank. J Trauma. 2010;68(5):1134-1138.

18. Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41(6):989-1001.

19. Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med. 2007;33(6):970-977.

20. Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, et al. Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore). 2004;83(5):274-279.

21. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35(4):584-588; discussion 588-589.

22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.

23. Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med. 2015;43(3):567-573.